S182 Impact of Novel Advanced Therapies on Primary Sclerosing Cholangitis in Patients With Comorbid Inflammatory Bowel DiseasesSarah Khan, Katherine Falloon, Zehra Naseem et al.|The American Journal of Gastroenterology|2024Cited by 0
Tu1828: SAFETY OF JAK INHIBITORS IN PRIMARY SCLEROSING CHOLANGITIS WITH COMORBID INFLAMMATORY BOWEL DISEASE: IMPORTANCE OF CLOSE LIVER MONITORINGZehra Naseem, Katherine Falloon, Sarah Khan et al.|Gastroenterology|2025Cited by 0
Mo1544: IMPACT OF NOVEL ADVANCED THERAPIES ON PRIMARY SCLEROSING CHOLANGITIS IN PATIENTS WITH COMORBID INFLAMMATORY BOWEL DISEASESZehra Naseem, Katherine Falloon, Sarah Khan et al.|Gastroenterology|2025Cited by 0
Mo1550: RISANKIZUMAB DECREASES ALKALINE PHOSPHATASE LEVELS IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS AND COMORBID INFLAMMATORY BOWEL DISEASESSarah Khan, Katherine Falloon, Florian Rieder et al.|Gastroenterology|2025Cited by 0